IEX •
Healthcare •
Biotechnology •
Quote as of 08/14/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization30.97 mln
Float3.85 mln
Earnings Date04/23/2027
EPS
364
Exceptional
P / E
0.00
Anomalous
Piotroski F-Score
4
/ 9
Borderline
1-Year Forecast
80.00
Transformational upside
Relative Strength
1
/ 100
Severely lagging
Debt / Equity
0.00
Debt-free
Business Description
Enlivex is an Israeli biotech company founded in 2005 and based in Ness Ziona, focused on developing a cell-based treatment called Allocetra that works by retraining immune cells known as macrophages. The company is testing this therapy across several serious medical conditions, including knee joint disease, jaw joint disorders, and life-threatening organ failure caused by sepsis. Clinical trials are currently underway at various stages for each of these conditions.
